EP Patent

EP3318562A3 — Benzylbenzene derivatives and methods of use

Assigned to Theracos Sub LLC · Expires 2018-09-12 · 8y expired

What this patent protects

Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combina…

USPTO Abstract

Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition, such as diabetes mellitus. The compounds have formula IA below.

Drugs covered by this patent

Patent Metadata

Patent number
EP3318562A3
Jurisdiction
EP
Classification
—
Expires
2018-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Theracos Sub LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.